These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8277513)
21. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors. Malmberg A; Nordvall G; Johansson AM; Mohell N; Hacksell U Mol Pharmacol; 1994 Aug; 46(2):299-312. PubMed ID: 8078492 [TBL] [Abstract][Full Text] [Related]
22. 1-Phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes and related derivatives as ligands for the neuromodulatory sigma 3 receptor: further structure-activity relationships. Wyrick SD; Booth RG; Myers AM; Owens CE; Bucholtz EC; Hooper PC; Kula NS; Baldessarini RJ; Mailman RB J Med Chem; 1995 Sep; 38(19):3857-64. PubMed ID: 7562917 [TBL] [Abstract][Full Text] [Related]
23. [3H]7-OH-DPAT labels both dopamine D3 receptors and sigma sites in the bovine caudate nucleus. Schoemaker H Eur J Pharmacol; 1993 Oct; 242(3):R1-2. PubMed ID: 8281986 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors. Dutta AK; Venkataraman SK; Fei XS; Kolhatkar R; Zhang S; Reith ME Bioorg Med Chem; 2004 Aug; 12(16):4361-73. PubMed ID: 15265488 [TBL] [Abstract][Full Text] [Related]
25. Modulation of dopamine D3 receptor binding by N-ethylmaleimide and neurotensin. Liu Y; Hillefors-Berglund M; von Euler G Brain Res; 1994 Apr; 643(1-2):343-8. PubMed ID: 7913398 [TBL] [Abstract][Full Text] [Related]
26. Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors. Levant B; Grigoriadis DE; De Souza EB Eur J Pharmacol; 1995 May; 278(3):243-7. PubMed ID: 7589161 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5'-(18)F-fluoropentyl)aminotetralin ((18)F-5-OH-FPPAT) in rodents and nonhuman primates. Shi B; Narayanan TK; Christian BT; Chattopadhyay S; Mukherjee J Nucl Med Biol; 2004 Apr; 31(3):303-11. PubMed ID: 15028242 [TBL] [Abstract][Full Text] [Related]
28. Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior. Neisewander JL; Fuchs RA; Tran-Nguyen LT; Weber SM; Coffey GP; Joyce JN Neuropsychopharmacology; 2004 Aug; 29(8):1479-87. PubMed ID: 15100700 [TBL] [Abstract][Full Text] [Related]
29. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Murray AM; Ryoo HL; Gurevich E; Joyce JN Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11271-5. PubMed ID: 7972046 [TBL] [Abstract][Full Text] [Related]
33. Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide. Kung HF; Kasliwal R; Pan SG; Kung MP; Mach RH; Guo YZ J Med Chem; 1988 May; 31(5):1039-43. PubMed ID: 2966245 [TBL] [Abstract][Full Text] [Related]
34. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats. Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310 [TBL] [Abstract][Full Text] [Related]
38. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin. Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561 [TBL] [Abstract][Full Text] [Related]